<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="es"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?OLF?><front><journal-meta><journal-id journal-id-type="nlm-ta">Enferm Infecc Microbiol Clin</journal-id><journal-id journal-id-type="iso-abbrev">Enferm. Infecc. Microbiol. Clin</journal-id><journal-title-group><journal-title>Enfermedades Infecciosas Y Microbiologia Clinica</journal-title></journal-title-group><issn pub-type="ppub">0213-005X</issn><issn pub-type="epub">1578-1852</issn><publisher><publisher-name>Sociedad Espa&#x000f1;ola de Enfermedades Infecciosas y Microbiolog&#x000ed;a Cl&#x000ed;nica. Published by Elsevier Espa&#x000f1;a, S.L.U.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7365066</article-id><article-id pub-id-type="publisher-id">S0213-005X(20)30249-4</article-id><article-id pub-id-type="doi">10.1016/j.eimc.2020.06.017</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Coinfecci&#x000f3;n por COVID-19 y gripe A: una cuesti&#x000f3;n de principios</article-title><trans-title-group xml:lang="en"><trans-title>COVID-19 and influenza A coinfection: a matter of principle</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" id="aut0005"><name><surname>Lozano-Parras</surname><given-names>M. Angeles</given-names></name><email>manglozano@gmail.com</email><xref rid="aff0005" ref-type="aff">a</xref><xref rid="cor0005" ref-type="corresp">&#x0204e;</xref></contrib><contrib contrib-type="author" id="aut0010"><name><surname>Amann-Ar&#x000e9;valo</surname><given-names>Marta</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="aut0015"><name><surname>Ciller-Mart&#x000ed;nez</surname><given-names>Marta</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="aut0020"><name><surname>Culebras-L&#x000f3;pez</surname><given-names>Esther</given-names></name><xref rid="aff0010" ref-type="aff">b</xref></contrib><aff id="aff0005"><label>a</label>Servicio de Medicina Interna. Hospital Cl&#x000ed;nico San Carlos, Madrid, Espa&#x000f1;a</aff><aff id="aff0010"><label>b</label>Servicio de Microbiolog&#x000ed;a. Hospital Cl&#x000ed;nico San Carlos, Madrid, Espa&#x000f1;a</aff></contrib-group><author-notes><corresp id="cor0005"><label>&#x0204e;</label>Autor para correspondencia. <email>manglozano@gmail.com</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>16</day><month>7</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="epub"><day>16</day><month>7</month><year>2020</year></pub-date><permissions><copyright-statement>&#x000a9; 2020 Sociedad Espa&#x000f1;ola de Enfermedades Infecciosas y Microbiolog&#x000ed;a Cl&#x000ed;nica. Published by Elsevier Espa&#x000f1;a, S.L.U. All rights reserved.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Sociedad Espa&#x000f1;ola de Enfermedades Infecciosas y Microbiolog&#x000ed;a Cl&#x000ed;nica</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions></article-meta></front><body><p content-type="salutation"><italic>Sr. Editor:</italic></p><p id="par0005">En noviembre de 2019 surgi&#x000f3; una nueva emergencia sanitaria en la ciudad de Wuhan ante el primer caso de infecci&#x000f3;n por COVID-19 en el mundo<xref rid="bib0055" ref-type="bibr"><sup>1</sup></xref>, mientras Espa&#x000f1;a sufr&#x000ed;a su propia epidemia de gripe estacional. El primer paciente registrado en nuestro pa&#x000ed;s con infecci&#x000f3;n por coronavirus fue notificado por el Centro Nacional de Microbiolog&#x000ed;a el 31 de enero de 2020 en La Gomera, trat&#x000e1;ndose de un turista alem&#x000e1;n. Hasta el 24 de febrero no hay comunicaci&#x000f3;n de casos a nivel de la Pen&#x000ed;nsula, detect&#x000e1;ndose uno en Barcelona, igualmente como caso importado. Cada vez hay m&#x000e1;s voces que se atreven a afirmar que la epidemia de gripe A acontecida en nuestro pa&#x000ed;s pudo enmascarar la llegada del virus semanas antes de lo confirmado en registros oficiales<xref rid="bib0060" ref-type="bibr"><sup>2</sup></xref>.</p><p id="par0010">Presentamos el caso de una paciente ingresada en nuestro hospital el 18 de enero de 2020 por neumon&#x000ed;a bilateral por gripe A en la que la determinaci&#x000f3;n posterior, mediante prueba de PCR del exudado nasofar&#x000ed;ngeo tomado a su ingreso, confirmaba la coinfecci&#x000f3;n por COVID-19. Se trata de una paciente de 46 a&#x000f1;os, natural de Madrid, sin antecedentes epidemiol&#x000f3;gicos de inter&#x000e9;s, que acude tras comienzo de cuadro cl&#x000ed;nico el 13 de enero consistente en tos seca persistente precipitada por las excursiones respiratorias, fiebre de hasta 38&#x000a0;&#x000b0;<sc>C</sc>, artromialgias, postraci&#x000f3;n importante y disnea progresivamente en aumento. En la exploraci&#x000f3;n destaca una temperatura de 40&#x000a0;&#x000b0;C, tensi&#x000f3;n arterial 95/64, frecuencia cardiaca: 95&#x000a0;lpm, y saturaci&#x000f3;n de O<sub>2</sub>: 89%. Se ausculta r&#x000ed;tmica sin soplos con crepitantes secos de despegamiento en ambos campos pulmonares. La anal&#x000ed;tica inicial presentaba 1.700 leucocitos/&#x003bc;L (1.100 neutr&#x000f3;filos, 500 linfocitos totales), hemoglobina 13&#x000a0;g/dL, hematocrito 36%, plaquetas 72.000, PCR de 1,5&#x000a0;mg/L, procalcitonina 0,09&#x000a0;ng/mL, ferritina 696&#x000a0;&#x003bc;g/L, CPK 516&#x000a0;U/L, LDH 712&#x000a0;UI/L, GPT 59&#x000a0;U/L, GPT 32&#x000a0;U/L y GGT 20&#x000a0;U/L. No se dispon&#x000ed;a del resultado de D-d&#x000ed;meros. En la radiograf&#x000ed;a de t&#x000f3;rax a su ingreso se apreciaba consolidaci&#x000f3;n en l&#x000f3;bulo superior izquierdo y perihiliar derecha. La toma de un exudado nasofar&#x000ed;ngeo confirma la infecci&#x000f3;n por gripe A. El ant&#x000ed;geno de neumococo y <italic>Legionella pneumophila</italic> serogrupo 1, as&#x000ed; como el cultivo de esputo resultan negativos. Se inicia tratamiento con oseltamivir, oxigenoterapia y antitusivos. Por empeoramiento cl&#x000ed;nico y radiol&#x000f3;gico a los cuatro d&#x000ed;as del ingreso, con mayor extensi&#x000f3;n de la consolidaci&#x000f3;n en el pulm&#x000f3;n izquierdo y perihiliar derecha, informada como &#x000ab;empeoramiento del proceso infeccioso bilateral o inflamatorio del tipo de neumon&#x000ed;a organizada&#x000bb;, se asocia levofloxacino JUNTO con corticoides sist&#x000e9;micos (<xref rid="fig0005" ref-type="fig">fig. 1</xref>
) que conduce a una r&#x000e1;pida respuesta cl&#x000ed;nica y radiol&#x000f3;gica, con normalizaci&#x000f3;n de los par&#x000e1;metros anal&#x000ed;ticos descritos, que permite alta hospitalaria con corticoides en pauta de descenso y saturaci&#x000f3;n basal del 95%. La paciente, asintom&#x000e1;tica desde el alta, solicit&#x000f3; a los cuatro meses por problema legal de su seguro m&#x000e9;dico y ante la situaci&#x000f3;n epidemiol&#x000f3;gica de pandemia por coronavirus, reevaluaci&#x000f3;n de PCR en la muestra recogida el 18 de enero, confirm&#x000e1;ndose la coinfecci&#x000f3;n por SARS CoV-2.<fig id="fig0005"><label>Figura 1</label><caption><p>Radiograf&#x000ed;a de t&#x000f3;rax al cuarto d&#x000ed;a de ingreso: progresi&#x000f3;n de la consolidaci&#x000f3;n en pulm&#x000f3;n izquierdo y perihiliar derecha. Peque&#x000f1;o derrame plural bilateral.</p></caption><graphic xlink:href="gr1_lrg"/></fig></p><p id="par0015">El inter&#x000e9;s de nuestro caso se basa en la constataci&#x000f3;n de la presencia de la infecci&#x000f3;n por COVID-19 en Espa&#x000f1;a, previa a los datos reportados hasta el momento, la circunstancia de una coinfecci&#x000f3;n con gripe A en el mismo proceso<xref rid="bib0065" ref-type="bibr"><sup>3</sup></xref>, as&#x000ed; como la r&#x000e1;pida resoluci&#x000f3;n del cuadro cl&#x000ed;nico y radiol&#x000f3;gico con el uso de esteroides sist&#x000e9;micos. A pesar de su reconocida eficacia en el tratamiento de s&#x000ed;ntomas respiratorios graves durante los brotes previos por otros coronavirus (SARS y MERS)<xref rid="bib0070" ref-type="bibr"><sup>4</sup></xref>, existe una fuerte recomendaci&#x000f3;n en contra de su utilizaci&#x000f3;n en la m&#x000fa;ltiple literatura vertida a ra&#x000ed;z de la pandemia<xref rid="bib0075" ref-type="bibr">5</xref>, <xref rid="bib0080" ref-type="bibr">6</xref>, <xref rid="bib0085" ref-type="bibr">7</xref>. Los estudios previos asocian a su uso un retraso en la liberaci&#x000f3;n del virus sin clara mejor&#x000ed;a en la supervivencia, mientras que empiezan a exponerse resultados sobre reducci&#x000f3;n de mortalidad en estadios evolutivos concretos, una vez controlada la replicaci&#x000f3;n viral<xref rid="bib0090" ref-type="bibr"><sup>8</sup></xref>, que reflejan los beneficios en cuanto a su utilizaci&#x000f3;n como inmunomodulador en fase inflamatoria de la infecci&#x000f3;n. Los hallazgos anatomopatol&#x000f3;gicos encontrados en series de casos sobre el da&#x000f1;o pulmonar asociado con el virus, como la formaci&#x000f3;n de membranas hialinas y datos de neumonitis fibrinoide organizada, podr&#x000ed;an justificar su administraci&#x000f3;n en esas circunstancias, para prevenir el desarrollo posterior de <italic>distress</italic> respiratorio<xref rid="bib0095" ref-type="bibr">9</xref>, <xref rid="bib0100" ref-type="bibr">10</xref>. Esperamos que el tiempo y un mejor conocimiento sobre la enfermedad aporten m&#x000e1;s evidencias sobre su empleo.</p><p id="par0020">Palabras clave: COVID-19, influenza, coinfection, esteroids, principles.</p></body><back><ref-list id="bibl0005"><title>Bibliograf&#x000ed;a</title><ref id="bib0055"><label>1</label><element-citation publication-type="journal" id="sbref0055"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Guan</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Tong</surname><given-names>Y.</given-names></name></person-group><article-title>Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia</article-title><source>N Engl J Med.</source><volume>382</volume><year>2020</year><fpage>1199</fpage><lpage>1207</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa2001316</pub-id><pub-id pub-id-type="pmid">31995857</pub-id></element-citation></ref><ref id="bib0060"><label>2</label><element-citation publication-type="journal" id="sbref0060"><person-group person-group-type="author"><name><surname>Coma</surname><given-names>E.</given-names></name><name><surname>Mora</surname><given-names>N.</given-names></name><name><surname>Prats-Uribe</surname><given-names>A.</given-names></name><name><surname>Fina</surname><given-names>F.</given-names></name><name><surname>Prieto-Alhambra</surname><given-names>D.</given-names></name><name><surname>Medina-Peralta</surname><given-names>M.</given-names></name></person-group><article-title>Excess cases of influenza suggest an earlier start to the coronavirus epidemic in Spain than official figures tell us: an analysis of primary care electronic medical records from over 6 million people from Catalonia</article-title><source>Medrxiv.</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2020.04.09.20056259</pub-id></element-citation></ref><ref id="bib0065"><label>3</label><element-citation publication-type="journal" id="sbref0065"><person-group person-group-type="author"><name><surname>Konala</surname><given-names>V.M.</given-names></name><name><surname>Adapa</surname><given-names>S.</given-names></name><name><surname>Gayam</surname><given-names>V.</given-names></name><name><surname>Naramala</surname><given-names>S.</given-names></name><name><surname>Daggubati</surname><given-names>S.R.</given-names></name><name><surname>Kammari</surname><given-names>C.B.</given-names></name></person-group><article-title>Co-infection with Influenza A and COVID-19</article-title><source>Eur J Case Rep Intern Med.</source><volume>7</volume><year>2020</year><fpage>001656</fpage><pub-id pub-id-type="doi">10.12890/2020_001656</pub-id><pub-id pub-id-type="pmid">32399452</pub-id></element-citation></ref><ref id="bib0070"><label>4</label><element-citation publication-type="journal" id="sbref0070"><person-group person-group-type="author"><name><surname>Griffiths</surname><given-names>M.J.D.</given-names></name><name><surname>McAuley</surname><given-names>D.F.</given-names></name><name><surname>Perkins</surname><given-names>G.D.</given-names></name><name><surname>Barrett</surname><given-names>N.</given-names></name><name><surname>Blackwood</surname><given-names>B.</given-names></name><name><surname>Boyle</surname><given-names>A.</given-names></name></person-group><article-title>Guidelines on the management of acute respiratory distress syndrome</article-title><source>BMJ Open Respir Res.</source><volume>6</volume><year>2019</year><fpage>e000420</fpage><pub-id pub-id-type="doi">10.1136/bmjresp-2019-000420</pub-id></element-citation></ref><ref id="bib0075"><label>5</label><element-citation publication-type="journal" id="sbref0075"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>C.D.</given-names></name><name><surname>Millar</surname><given-names>J.E.</given-names></name><name><surname>Baillie</surname><given-names>J.K.</given-names></name></person-group><article-title>Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury</article-title><source>Lancet.</source><volume>395</volume><year>2020</year><fpage>473</fpage><lpage>475</lpage><pub-id pub-id-type="pmid">32043983</pub-id></element-citation></ref><ref id="bib0080"><label>6</label><element-citation publication-type="journal" id="sbref0080"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>Clinical management of severe acute respiratory infection (???SARI)??? when COVID-19 disease is suspected: interim guidance, 13 March 2020</source><year>2020</year><comment>Disponible en: https://apps.who.int/iris/handle/10665/331446</comment></element-citation></ref><ref id="bib0085"><label>7</label><element-citation publication-type="journal" id="sbref0085"><person-group person-group-type="author"><name><surname>Bhimraj</surname><given-names>A.</given-names></name><name><surname>Morgan</surname><given-names>R.L.</given-names></name><name><surname>Shumaker</surname><given-names>A.H.</given-names></name><name><surname>Lavergne</surname><given-names>V.</given-names></name><name><surname>Baden</surname><given-names>L.</given-names></name><name><surname>Cheng</surname><given-names>V.C.C.</given-names></name></person-group><article-title>Infectious diseases Society of America guidelines on the treatment and management of patients with COVID-19</article-title><source>Clin Infect Dis.</source><year>2020, doi: 10.1093/cid/ciaa478</year></element-citation></ref><ref id="bib0090"><label>8</label><element-citation publication-type="journal" id="sbref0090"><person-group person-group-type="author"><collab>Recovery-randomised evaluation of COVID-19 therapy</collab></person-group><source>Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19</source><year>2020</year><comment>Disponible en: https://www.recoverytrial.net/news/low-cost-dexamethasone-reduces-death-by-up-to-one-third-in-hospitalised-patients-with-severe-respiratory-complications-of-covid-19</comment></element-citation></ref><ref id="bib0095"><label>9</label><element-citation publication-type="journal" id="sbref0095"><person-group person-group-type="author"><name><surname>Goursaud</surname><given-names>S.</given-names></name><name><surname>Descamps</surname><given-names>R.</given-names></name><name><surname>Daubin</surname><given-names>C.</given-names></name><name><surname>du Cheyron</surname><given-names>D.</given-names></name><name><surname>Valette</surname><given-names>X.</given-names></name></person-group><article-title>Corticosteroid use in selected patients with severe acute respiratory distress syndrome related to Covid-19</article-title><source>J Infect.</source><volume>S0163-4453</volume><year>2020</year><fpage>30299-1</fpage><pub-id pub-id-type="doi">10.1016/j.jinf.2020.05.023</pub-id></element-citation></ref><ref id="bib0100"><label>10</label><element-citation publication-type="journal" id="sbref0100"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name></person-group><article-title>Pathological findings of COVID-19 associated with acute respiratory distress syndrome</article-title><source>Lancet Respir Med.</source><volume>8</volume><year>2020</year><fpage>420</fpage><lpage>26422</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(20)30076-X</pub-id><pub-id pub-id-type="pmid">32085846</pub-id></element-citation></ref></ref-list></back></article>